Free Historical Stock Data on St. Jude Medical
Stock Symbol: STJ
|Receive a complete Daily History of this Stock
You can receive a complete daily file of this issue since 1970 or stock inception. We will email you the file
in ASCII format within a few hours or ordering.
Product Details | Order
St. Jude Medical, Inc. is engaged in the development, manufacturing and distribution of cardiovascular medical devices for the global cardiac rhythm management (CRM), cardiology and vascular access (C/VA) and cardiac surgery (CS) markets. The Company's principal products in each of these markets are bradycardia pacemaker systems, tachycardia implantable cardioverter defibrillator (ICD) systems and electrophysiology (EP) catheters in CRM; vascular closure devices, catheters, guidewires and introducers in C/VA, and mechanical and tissue heart valves, valve repair products and suture-free devices to facilitate coronary artery bypass graft anastomoses in CS. St. Jude markets its products primarily in the United States, Western Europe and Japan. The Company also sells its products in Eastern Europe, Africa, the Middle East, Canada, Latin America and the Asia-Pacific region through employee-based sales organizations and independent distributors.
St. Jude Medical designs, manufactures, and markets medical devices primarily for cardiac care. Products include heart valve disease management devices, cardiac rhythm management and interventional cardiology devices. For the six months ended 6/30/02, revenues rose 17% to $775.5 million. Net income rose 45% to $131.6 million. Results reflect increased bradycardia, ICD and electrophysiology catheter unit sales and the absence of a $5 million purchased in-process R&D charge.